| Anthem Biosciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544449 |
NSE Symbol : ANTHEM |
P/E(TTM) : 59.74 |
|
ISIN Demat : INE0CZ201020 |
Div & Yield% : 0.00 |
EPS(TTM) : 10.64 |
|
Book Value(₹) : 50.81 |
Market Cap(₹Cr) : 35,695.93 |
Face Value(₹) : 2.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,840.65 | 1,417.54 | 1,056.92 | 1,231.26 | 1,103.24 |
| Other Income | 109.44 | 70.52 | 139.17 | 48.98 | 37.21 |
| Stock Adjustments | 86.70 | 41.23 | 9.01 | 1.37 | -39.12 |
| Total Income | 2,036.79 | 1,529.29 | 1,205.10 | 1,281.61 | 1,101.33 |
| EXPENDITURE : | |||||
| Raw Materials | 828.08 | 640.77 | 348.29 | 410.30 | 407.88 |
| Power and Fuel Cost | 42.56 | 31.29 | 38.95 | 36.32 | 34.23 |
| Other Manufacturing Expenses | 46.27 | 34.13 | 21.11 | 23.38 | 22.76 |
| Selling and Administration Expenses | 56.41 | 54.67 | 60.66 | 48.21 | 33.66 |
| Miscellaneous Expenses | 13.08 | 10.25 | 12.68 | 11.46 | 15.67 |
| Employee Benefit Expenses | 251.76 | 182.65 | 153.24 | 137.51 | 142.19 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 798.65 | 575.52 | 570.19 | 614.44 | 444.95 |
| Interest | 9.29 | 9.26 | 8.71 | 10.09 | 16.97 |
| Gross Profit | 789.36 | 566.26 | 561.48 | 604.35 | 427.98 |
| Depreciation | 77.94 | 81.49 | 63.70 | 57.76 | 62.40 |
| Profit Before Tax | 711.42 | 484.77 | 497.78 | 546.59 | 365.58 |
| Current Tax | 182.03 | 126.41 | 120.05 | 142.39 | 96.70 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 23.21 | -16.42 | -7.94 | -1.79 | -2.43 |
| Reported Net Profit | 506.19 | 374.78 | 385.67 | 405.99 | 271.31 |
| Extraordinary Items | -0.26 | -0.21 | 40.84 | -0.14 | -0.14 |
| Adjusted Net Profit | 506.45 | 374.99 | 344.83 | 406.13 | 271.45 |
| Adjustment below Net Profit | -50.62 | -71.60 | -139.35 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | 1,524.15 | 1,220.97 | 974.65 | 568.66 | 362.71 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 26.08 |
| P & L Balance carried down | 1,979.72 | 1,524.15 | 1,220.97 | 974.65 | 607.93 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 9.05 | 6.70 | 6.76 | 462.60 | 319.76 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 44.24 | 34.58 | 30.53 | 1,544.46 | 826.76 |
| Book Value(Adj)-Unit Curr | - | - | - | - | - |